The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Alice T. Shaw

Alice Shaw

Clinical Investigator, 2008-2014


KI Research Areas of Focus:
Nano-based Drugs, Personalized Medicine

Alice T. Shaw, M.D., Ph.D. is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital and an assistant professor of medicine at Harvard Medical School.

Dr. Shaw’s major research interests include studying anaplastic lymphoma kinase (ALK) translocations in non-small cell lung carcinoma (NSCLS); developing targeted strategies to treat NSCLCs harboring activating KRAS mutations; discovering new targets in NSCLC using both genetic and phosphoproteomic strategies; and developing novel nanoparticle-based siRNA delivery systems to target genetically defined subsets of lung cancer.

Dr. Shaw has been awarded a number of research grants, including grants from the Damon Runyon Cancer Research Foundation, the Burroughs Welcome Fund, the V Foundation for Cancer Research, and the NIH/NCI.